PIK3CB and neoplasm: RNA pulldown experiments and RNA immunoprecipitation (RIP) assays showed that LINC00152 interacted with EGF receptor (EGFR) to constitutively activate EGFR and subsequently, the PI3K/AKT signaling pathway, leading to increased tumor cell proliferation (Zhou et al., 2015).